Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Stock Information for Talphera Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Talphera Inc.

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
Talphera Announces the Appointment of Joe Todisco to Board of Directors
CorMedix Announces Strategic Minority Investment in Talphera
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.